SCARs Label Warning For OTC PPIs In US Starts With Perrigo’s 131 Omeprazole Product Options
FDA approves warning for severe cutaneous adverse reactions on labeling for Perrigo's 131 20-mg omeprazole delayed-release tablet products across unflavored and cool mint or wild berry-mint options and 14-, 28- and 42-count packages.
